Monday 10 p.m. COVID-19 updateMonday 10 p.m. COVID-19 update
Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 TrialsModerna announced Monday that their COVID-19 vaccine candidate is showing 94.5% efficacy; KDKA's Amy Wadas reports.
WEB EXTRA: Moderna Statement On COVID VaccineDrug company Moderna released a statement Monday (11/16) saying its COVID-19 vaccine is 94.5% effective. CEO Stéphane Bancel said the results from a late-stage study are "the first clinical validation..